Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patients

Linezolid is now recommended as a first line drug for Multidrug Resistant Tuberculosis (MDR-TB). Previous studies reported hematologic toxicity as one of the main side effects. The mechanism of this toxicity is mitochondrial dysfunction, for which a biomarker is Growth differentiation factor-15 (GDF...

Descripción completa

Detalles Bibliográficos
Autores principales: Oehadian, Amaylia, Santoso, Prayudi, Menzies, Dick, Ruslami, Rovina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358446/
https://www.ncbi.nlm.nih.gov/pubmed/35957807
http://dx.doi.org/10.1016/j.idcr.2022.e01591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358446/
https://www.ncbi.nlm.nih.gov/pubmed/35957807
http://dx.doi.org/10.1016/j.idcr.2022.e01591

Ejemplares similares